Collaboration - October 16, 2017
Billion SEK investment in life science cluster in Mölndal
The investment of 3,5 billion SEK, presented by Next Step and Vectura in collaboration with AstraZeneca, will enable the formation of a new arena for life science and innovation in Gothenburg. The aim is that the new cluster will become a leading international research cluster. It will be established in the area of AstraZeneca’s facilities […]
Drug Development Pharma - March 27, 2013
AstraZeneca keeps R&D in Mölndal
AstraZeneca’s site in Mölndal will continue to be a global center for research and development, the company recently announced. At the same time, another 2 300 employees are being made redundant. The company plans to invest in strategic R&D centers in the UK, the US and Mölndal, Sweden, focusing on small molecule and biologics R&D […]